Search

Search Results
Results 3061 - 3070 of 3070 for Abuse, child
  • News - 27 Mar 2010
    CRC Health Corporation, a leading provider of substance abuse treatment and youth services through its wholly owned consolidated subsidiaries, announced its results for the fourth quarter and twelve...
  • News - 1 Dec 2004
    Women represent the fastest growing segment of the population living with HIV in Latin America and the Caribbean, and new efforts are urgently needed to halt the spread of the epidemic in the female...
  • Drug - 16 Jan 2026
    Consumer Medicine Information (CMI) about Sublocade intended for persons living in Australia.
  • Drug - 15 Oct 2025
    Consumer Medicine Information (CMI) about Buvidal Weekly and Buvidal Monthly intended for persons living in Australia.
  • Drug - 30 Sep 2025
    Consumer Medicine Information (CMI) about DBL Morphine Sulfate intended for persons living in Australia.
  • Drug - 17 Jul 2025
    Consumer Medicine Information (CMI) about DBL Pethidine Hydrochloride intended for persons living in Australia.
  • Drug - 29 Apr 2025
    Consumer Medicine Information (CMI) about Midazolam Injection intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Ketalar intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Midazolam Viatris intended for persons living in Australia.
  • Health - 19 Jun 2023
    Diagnosis of eating disorders is a process that begins with acceptance of its presence. Often the patient needs to be convinced of its presence as there is severe denial and resistance to the problem.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.